Stock data

訊聯 (1784)

訊聯 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$97.04M, up 7.4% from a year earlier. EPS over the last four quarters totals NT$1.14.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 訊聯 in Insightr